Motif ID: Sp1
Z-value: 1.707
Transcription factors associated with Sp1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Sp1 | ENSMUSG00000001280.6 | Sp1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Sp1 | mm10_v2_chr15_+_102406143_102406380 | 0.10 | 4.5e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 21.2 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 5.2 | 5.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 4.9 | 19.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 4.4 | 13.3 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 4.3 | 17.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 4.2 | 12.5 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 4.2 | 12.5 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 4.0 | 12.0 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
| 3.8 | 3.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 3.7 | 11.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 3.5 | 10.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 3.5 | 10.6 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 3.4 | 10.2 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 3.2 | 9.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 3.1 | 9.3 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 3.1 | 21.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 3.0 | 18.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 3.0 | 8.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.9 | 14.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.8 | 28.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 2.8 | 11.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 2.7 | 8.2 | GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
| 2.7 | 2.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 2.7 | 10.8 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 2.6 | 23.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
| 2.6 | 13.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 2.6 | 20.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 2.6 | 7.8 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 2.5 | 2.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 2.4 | 7.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 2.4 | 16.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.3 | 9.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 2.3 | 9.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 2.3 | 11.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 2.2 | 9.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 2.2 | 8.9 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 2.2 | 13.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.2 | 11.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 2.1 | 17.2 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 2.1 | 6.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.1 | 2.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 2.1 | 6.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.1 | 10.7 | GO:0015871 | choline transport(GO:0015871) |
| 2.1 | 8.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 2.1 | 8.4 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 2.1 | 10.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.1 | 6.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 2.1 | 10.3 | GO:0070417 | cellular response to cold(GO:0070417) |
| 2.0 | 6.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 2.0 | 2.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 2.0 | 8.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
| 2.0 | 5.9 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 2.0 | 7.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.9 | 7.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.9 | 5.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 1.9 | 9.5 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.9 | 11.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.9 | 9.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 1.9 | 7.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 1.9 | 9.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 1.9 | 9.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.9 | 11.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.8 | 12.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.8 | 29.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.8 | 1.8 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 1.8 | 12.7 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 1.8 | 5.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 1.8 | 5.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 1.8 | 7.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.8 | 7.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
| 1.8 | 3.5 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.8 | 7.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 1.8 | 5.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.8 | 1.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.7 | 3.5 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 1.7 | 5.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 1.7 | 6.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 1.7 | 5.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 1.7 | 6.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 1.7 | 5.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 1.7 | 3.4 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 1.7 | 15.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.7 | 3.4 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
| 1.7 | 8.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.7 | 5.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 1.7 | 10.1 | GO:1903056 | positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 1.7 | 6.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.7 | 13.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 1.6 | 3.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 1.6 | 6.6 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.6 | 1.6 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.6 | 8.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.6 | 13.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 1.6 | 6.5 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 1.6 | 1.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 1.6 | 4.8 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 1.6 | 4.8 | GO:0015866 | ADP transport(GO:0015866) |
| 1.6 | 3.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
| 1.6 | 4.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.6 | 4.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.5 | 9.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 1.5 | 4.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 1.5 | 6.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.5 | 4.6 | GO:1902022 | L-lysine transport(GO:1902022) |
| 1.5 | 9.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.5 | 3.0 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
| 1.5 | 4.5 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.5 | 4.5 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.5 | 5.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.5 | 4.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 1.5 | 8.8 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 1.5 | 14.7 | GO:0046959 | habituation(GO:0046959) |
| 1.5 | 16.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 1.5 | 7.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 1.5 | 4.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.4 | 1.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.4 | 4.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 1.4 | 7.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 1.4 | 1.4 | GO:0009651 | response to salt stress(GO:0009651) |
| 1.4 | 5.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.4 | 14.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 1.4 | 2.8 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 1.4 | 8.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 1.4 | 11.3 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 1.4 | 8.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 1.4 | 12.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 1.4 | 1.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 1.4 | 4.2 | GO:0007525 | somatic muscle development(GO:0007525) |
| 1.4 | 4.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.4 | 4.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
| 1.4 | 5.5 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.4 | 5.5 | GO:0009597 | detection of virus(GO:0009597) |
| 1.4 | 5.5 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 1.4 | 8.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 1.3 | 4.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
| 1.3 | 6.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.3 | 2.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.3 | 4.0 | GO:0060596 | mammary placode formation(GO:0060596) |
| 1.3 | 9.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.3 | 23.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.3 | 2.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.3 | 1.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 1.3 | 2.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 1.3 | 6.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.3 | 6.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 1.3 | 5.2 | GO:0009405 | pathogenesis(GO:0009405) |
| 1.3 | 9.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 1.3 | 3.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.3 | 2.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 1.3 | 3.9 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
| 1.3 | 6.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.3 | 14.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.3 | 7.7 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 1.3 | 2.6 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.3 | 3.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.3 | 7.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 1.3 | 10.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 1.3 | 6.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 1.3 | 6.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 1.3 | 3.8 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 1.2 | 18.6 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.2 | 2.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 1.2 | 7.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.2 | 18.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 1.2 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 1.2 | 8.6 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.2 | 6.1 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.2 | 9.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.2 | 8.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 1.2 | 4.8 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 1.2 | 2.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.2 | 4.8 | GO:0021586 | pons maturation(GO:0021586) |
| 1.2 | 4.8 | GO:0015817 | histidine transport(GO:0015817) |
| 1.2 | 8.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 1.2 | 3.5 | GO:0061744 | motor behavior(GO:0061744) |
| 1.2 | 5.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.2 | 2.3 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.2 | 1.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 1.2 | 4.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 1.2 | 7.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 1.2 | 2.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.2 | 9.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 1.2 | 2.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 1.2 | 11.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.1 | 12.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 1.1 | 8.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.1 | 10.3 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.1 | 3.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.1 | 1.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 1.1 | 3.4 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 1.1 | 15.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.1 | 5.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.1 | 11.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 1.1 | 3.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
| 1.1 | 1.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 1.1 | 3.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.1 | 3.3 | GO:0015816 | glycine transport(GO:0015816) |
| 1.1 | 4.4 | GO:0090472 | dibasic protein processing(GO:0090472) |
| 1.1 | 3.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.1 | 1.1 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 1.1 | 3.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 1.1 | 7.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.1 | 3.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 1.1 | 1.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 1.1 | 5.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 1.1 | 3.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 1.1 | 5.3 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 1.1 | 8.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 1.1 | 4.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.0 | 9.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.0 | 1.0 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.0 | 4.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 1.0 | 1.0 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 1.0 | 3.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 1.0 | 18.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 1.0 | 8.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.0 | 3.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 1.0 | 3.0 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.0 | 3.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.0 | 7.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 1.0 | 2.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
| 1.0 | 7.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.0 | 4.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.0 | 7.0 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 1.0 | 1.0 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
| 1.0 | 6.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 1.0 | 5.9 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.0 | 2.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 1.0 | 5.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.0 | 6.8 | GO:0015879 | carnitine transport(GO:0015879) |
| 1.0 | 1.9 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.0 | 5.8 | GO:0003383 | apical constriction(GO:0003383) |
| 1.0 | 5.8 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 1.0 | 1.9 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 1.0 | 5.8 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 1.0 | 2.9 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 1.0 | 9.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 1.0 | 7.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 1.0 | 1.9 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 1.0 | 1.0 | GO:1900372 | negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
| 0.9 | 4.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.9 | 4.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.9 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.9 | 3.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.9 | 2.8 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.9 | 0.9 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.9 | 2.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.9 | 0.9 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.9 | 2.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.9 | 2.8 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.9 | 1.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.9 | 8.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.9 | 2.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.9 | 2.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.9 | 6.4 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) |
| 0.9 | 2.7 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.9 | 0.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.9 | 0.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.9 | 6.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.9 | 7.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.9 | 3.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.9 | 8.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.9 | 2.6 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.9 | 20.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.9 | 4.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.9 | 4.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.9 | 0.9 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.9 | 2.6 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.9 | 6.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.9 | 3.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.9 | 5.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.9 | 2.6 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 0.9 | 3.4 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.8 | 5.9 | GO:0015862 | uridine transport(GO:0015862) |
| 0.8 | 2.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.8 | 2.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.8 | 4.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.8 | 0.8 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.8 | 1.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.8 | 3.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.8 | 0.8 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
| 0.8 | 1.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.8 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.8 | 12.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.8 | 0.8 | GO:0052151 | modulation by symbiont of host apoptotic process(GO:0052150) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.8 | 12.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.8 | 3.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.8 | 2.4 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.8 | 13.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.8 | 1.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.8 | 1.6 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.8 | 1.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.8 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.8 | 3.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.8 | 2.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.8 | 25.5 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.8 | 1.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.8 | 1.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.8 | 3.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.8 | 3.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.8 | 3.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.8 | 6.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.8 | 0.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 0.8 | 18.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.8 | 2.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.8 | 3.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.8 | 6.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.8 | 4.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 | 13.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.7 | 3.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.7 | 3.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.7 | 2.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.7 | 10.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.7 | 8.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.7 | 3.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.7 | 0.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.7 | 2.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.7 | 2.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.7 | 2.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.7 | 2.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.7 | 2.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.7 | 7.9 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.7 | 0.7 | GO:0060003 | copper ion export(GO:0060003) |
| 0.7 | 5.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.7 | 2.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.7 | 3.5 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.7 | 4.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.7 | 6.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.7 | 20.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.7 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.7 | 2.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.7 | 2.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.7 | 2.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 | 2.1 | GO:1990743 | protein sialylation(GO:1990743) |
| 0.7 | 2.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.7 | 11.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.7 | 2.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 | 2.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.7 | 2.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.7 | 3.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.7 | 1.4 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.7 | 0.7 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.7 | 6.8 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.7 | 0.7 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.7 | 5.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.7 | 13.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.7 | 0.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.7 | 1.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.7 | 2.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.7 | 3.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.7 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.7 | 2.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 | 4.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 | 4.7 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.7 | 3.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.7 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.7 | 2.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.6 | 3.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.6 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.6 | 3.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.6 | 2.6 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.6 | 3.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 | 3.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.6 | 4.4 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.6 | 5.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 | 1.9 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.6 | 10.1 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.6 | 1.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.6 | 0.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.6 | 5.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.6 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.6 | 1.9 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.6 | 2.5 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 0.6 | 11.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.6 | 5.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.6 | 0.6 | GO:2000830 | vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.6 | 4.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.6 | 1.9 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.6 | 4.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.6 | 2.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.6 | 2.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.6 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.6 | 14.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
| 0.6 | 1.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.6 | 2.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.6 | 1.8 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.6 | 5.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.6 | 2.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.6 | 40.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.6 | 1.8 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.6 | 4.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.6 | 3.0 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.6 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.6 | 1.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.6 | 2.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 | 0.6 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.6 | 2.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.6 | 1.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.6 | 4.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.6 | 2.9 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.6 | 2.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.6 | 2.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.6 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.6 | 1.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 | 2.9 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.6 | 2.3 | GO:0014889 | muscle atrophy(GO:0014889) |
| 0.6 | 2.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.6 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.6 | 2.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.6 | 0.6 | GO:0046479 | glycolipid catabolic process(GO:0019377) glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) ceramide catabolic process(GO:0046514) |
| 0.6 | 5.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 2.8 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.6 | 0.6 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.6 | 10.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.6 | 1.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.6 | 4.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.6 | 14.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.6 | 0.6 | GO:0060214 | stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) |
| 0.6 | 4.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
| 0.6 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.6 | 4.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.6 | 2.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.5 | 1.6 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.5 | 0.5 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.5 | 2.7 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.5 | 2.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.5 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.5 | 27.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.5 | 1.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.5 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 | 1.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.5 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.5 | 1.6 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) regulation of hydrogen peroxide biosynthetic process(GO:0010728) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.5 | 2.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.5 | 2.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.5 | 1.6 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.5 | 2.1 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.5 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.5 | 1.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.5 | 7.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.5 | 1.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.5 | 2.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 | 3.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 1.0 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.5 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.5 | 7.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.5 | 3.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.5 | 1.0 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.5 | 1.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.5 | 5.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 3.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.5 | 3.1 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.5 | 5.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.5 | 4.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 3.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.5 | 2.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.5 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.5 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.5 | 1.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.5 | 13.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.5 | 1.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.5 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.5 | 4.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.5 | 4.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.5 | 1.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.5 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.5 | 1.5 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.5 | 5.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.5 | 1.0 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
| 0.5 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.5 | 1.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.5 | 1.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.5 | 4.3 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.5 | 1.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.5 | 1.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.5 | 1.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.5 | 1.4 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.5 | 2.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.5 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.5 | 3.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.5 | 3.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.5 | 2.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.5 | 1.9 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.5 | 3.7 | GO:0030578 | PML body organization(GO:0030578) |
| 0.5 | 2.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.5 | 1.8 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 0.5 | 0.5 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.5 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.5 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.5 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.5 | 0.9 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
| 0.5 | 2.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.5 | 4.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.5 | 2.3 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.4 | 2.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.4 | 1.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.4 | 2.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 | 1.8 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.4 | 11.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.4 | 3.6 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.4 | 2.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.4 | 3.1 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.4 | 5.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 | 3.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.4 | 2.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.4 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.4 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
| 0.4 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.4 | 0.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 0.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.4 | 12.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.4 | 3.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 1.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.4 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.4 | 3.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.4 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.4 | 0.8 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.4 | 2.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.4 | 3.3 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
| 0.4 | 4.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.4 | 7.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 2.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.4 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.4 | 2.9 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.4 | 0.4 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.4 | 3.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 | 5.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
| 0.4 | 2.0 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 0.4 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.4 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.4 | 2.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 | 2.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.4 | 1.2 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 0.4 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.4 | 1.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.4 | 0.8 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) |
| 0.4 | 1.2 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.4 | 0.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.4 | 1.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.4 | 0.8 | GO:0032094 | response to food(GO:0032094) |
| 0.4 | 7.9 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 0.4 | 0.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
| 0.4 | 1.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 | 2.0 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.4 | 0.8 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
| 0.4 | 1.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 | 0.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.4 | 2.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.4 | 1.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
| 0.4 | 2.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.4 | 1.9 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.4 | 1.5 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.4 | 1.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.4 | 1.1 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
| 0.4 | 2.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.4 | 1.1 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.4 | 5.3 | GO:0051647 | nucleus localization(GO:0051647) |
| 0.4 | 1.9 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.4 | 0.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.4 | 2.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.4 | 3.8 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.4 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 2.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.4 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 | 3.0 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.4 | 3.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 | 3.0 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 4.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.4 | 6.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.4 | 1.1 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.4 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.4 | 0.4 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.4 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.4 | 1.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.4 | 2.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.4 | 4.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.4 | 6.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.4 | 4.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.4 | 1.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.4 | 2.5 | GO:0015844 | monoamine transport(GO:0015844) |
| 0.4 | 0.4 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.4 | 1.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 | 1.8 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
| 0.4 | 1.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.4 | 9.6 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.4 | 1.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.4 | 6.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.4 | 0.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.4 | 2.8 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
| 0.4 | 5.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.4 | 1.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.3 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.3 | 1.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 | 1.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.3 | 2.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.3 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.3 | 1.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 | 1.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.3 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 | 0.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 | 1.0 | GO:0051775 | response to redox state(GO:0051775) |
| 0.3 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 1.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 | 1.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 | 6.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.3 | 3.7 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.3 | 0.3 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.3 | 0.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.3 | 3.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 2.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.3 | 1.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.3 | 1.0 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 0.3 | 3.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.3 | 1.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.3 | 2.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.3 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.3 | 1.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 | 1.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.3 | 0.6 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
| 0.3 | 1.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 | 1.3 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.3 | 1.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.3 | 10.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.3 | 2.2 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 3.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.3 | 1.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.3 | 3.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 | 0.9 | GO:0001705 | ectoderm formation(GO:0001705) |
| 0.3 | 1.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.3 | 0.9 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
| 0.3 | 5.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.3 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.3 | 4.0 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.3 | 1.2 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.3 | 0.3 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.3 | 4.0 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.3 | 2.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.3 | 1.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.3 | 2.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 1.8 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
| 0.3 | 1.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 | 1.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.3 | 0.9 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
| 0.3 | 1.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 | 7.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.3 | 1.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.3 | 1.2 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.3 | 0.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
| 0.3 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 1.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.3 | 0.6 | GO:0019043 | establishment of viral latency(GO:0019043) |
| 0.3 | 1.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.3 | 7.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.3 | 0.9 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.3 | 0.9 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.3 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 | 5.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.3 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.3 | 2.0 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.3 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.3 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.3 | 7.2 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.3 | 1.7 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 0.3 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.3 | 0.8 | GO:0015882 | L-ascorbic acid transport(GO:0015882) L-ascorbic acid metabolic process(GO:0019852) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 | 0.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.3 | 1.6 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.3 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.3 | 3.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.3 | 6.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.3 | 1.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 2.1 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 | 0.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 0.3 | 0.5 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.3 | 0.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 | 0.5 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 | 1.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.3 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.3 | 0.3 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.3 | 2.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.3 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 | 0.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) negative regulation of ERAD pathway(GO:1904293) |
| 0.3 | 1.8 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.3 | 1.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.3 | 1.8 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.3 | 19.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.3 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.3 | 1.3 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.3 | 1.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.3 | 0.8 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 | 3.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.3 | 1.0 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
| 0.3 | 1.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.3 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.3 | 3.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 | 0.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 0.3 | 0.8 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.3 | 1.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.3 | 0.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.3 | 1.3 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 | 1.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.3 | 2.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 | 1.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.2 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.2 | 1.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 | 2.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 0.7 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 | 0.5 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 | 3.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 | 0.2 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 0.2 | 2.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.2 | 1.0 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 | 3.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.2 | 0.7 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 | 0.5 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.2 | 0.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 4.4 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.2 | 1.4 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.2 | 0.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.2 | 4.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.2 | 1.6 | GO:0071872 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
| 0.2 | 0.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 | 1.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.2 | 4.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.2 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 2.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.2 | 0.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.2 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 | 1.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 1.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 | 1.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.2 | 0.5 | GO:0045006 | DNA deamination(GO:0045006) |
| 0.2 | 13.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.2 | 1.6 | GO:0015858 | nucleoside transport(GO:0015858) |
| 0.2 | 5.3 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.2 | 1.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 | 5.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.2 | 1.3 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 0.2 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 1.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.2 | 1.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.2 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.3 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 0.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 4.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.2 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 2.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.2 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 1.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 0.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.4 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.2 | 0.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.2 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 | 11.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.2 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 0.8 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 0.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.2 | 2.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 1.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 | 0.6 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.2 | 2.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.2 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.2 | 1.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.2 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 1.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
| 0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 | 0.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 0.2 | 0.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.2 | 1.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.2 | 0.6 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
| 0.2 | 3.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.2 | 1.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 1.9 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.2 | 1.2 | GO:0033198 | response to ATP(GO:0033198) |
| 0.2 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 | 5.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 1.5 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 0.2 | 0.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.2 | 0.8 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.2 | 0.8 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.2 | 6.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 0.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
| 0.2 | 1.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 0.2 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.2 | 2.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 | 0.4 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.2 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 0.4 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.2 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.2 | 1.2 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.2 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 | 0.9 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 | 2.1 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 | 0.3 | GO:0046503 | glycerophospholipid catabolic process(GO:0046475) glycerolipid catabolic process(GO:0046503) |
| 0.2 | 0.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.2 | 1.4 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
| 0.2 | 1.2 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.2 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.2 | 1.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 | 2.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.2 | 3.8 | GO:0048536 | spleen development(GO:0048536) |
| 0.2 | 0.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 | 3.0 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.2 | 0.3 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.2 | 1.0 | GO:0001964 | startle response(GO:0001964) |
| 0.2 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 2.6 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 | 1.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 2.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.2 | 4.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 | 0.8 | GO:0009268 | response to pH(GO:0009268) |
| 0.2 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
| 0.2 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.2 | 0.8 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 0.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 | 0.2 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.2 | 1.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 0.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 | 0.3 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 | 2.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 0.7 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 | 1.8 | GO:0046033 | AMP metabolic process(GO:0046033) |
| 0.1 | 2.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
| 0.1 | 1.0 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 4.2 | GO:0030641 | regulation of cellular pH(GO:0030641) |
| 0.1 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 14.5 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.1 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 1.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 0.1 | 2.5 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 1.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.1 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
| 0.1 | 0.8 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.1 | 2.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 | 1.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.3 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) negative regulation of alpha-beta T cell proliferation(GO:0046642) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 | 0.8 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
| 0.1 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 0.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 1.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 0.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.9 | GO:0034243 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 1.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 0.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 2.2 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 0.5 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 | 0.5 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
| 0.1 | 2.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 0.3 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.1 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 | 1.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.1 | 0.2 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) glycoprotein transport(GO:0034436) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.1 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 | 0.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
| 0.1 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 | 4.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.4 | GO:0046684 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.1 | 3.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 1.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.1 | 0.4 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 1.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.1 | 0.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.1 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
| 0.1 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 1.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 | 0.2 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 | 0.7 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 1.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.1 | 1.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 | 0.2 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.1 | 3.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 1.2 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 0.2 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 1.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.1 | 1.2 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.2 | GO:0070723 | response to cholesterol(GO:0070723) |
| 0.1 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 0.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 | 0.1 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
| 0.1 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 2.6 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.1 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.1 | 0.1 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
| 0.1 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 1.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.4 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.1 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.1 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
| 0.1 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.5 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 0.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.5 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.1 | 5.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 0.3 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
| 0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 2.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 0.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.1 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) detection of external biotic stimulus(GO:0098581) |
| 0.1 | 0.3 | GO:0060004 | reflex(GO:0060004) |
| 0.1 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.1 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.0 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 | 0.5 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
| 0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 0.0 | 1.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.0 | 0.4 | GO:0017157 | regulation of exocytosis(GO:0017157) |
| 0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 2.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 1.4 | GO:0050905 | neuromuscular process(GO:0050905) |
| 0.0 | 0.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.0 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 | 0.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
| 0.0 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.0 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.4 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
| 0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 | 0.1 | GO:0042044 | water transport(GO:0006833) fluid transport(GO:0042044) |
| 0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 | 0.2 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 | 0.1 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
| 0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 | 0.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 | 0.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.0 | 0.0 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
| 0.0 | 0.0 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 | 0.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.0 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 3.8 | 3.8 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 3.5 | 10.5 | GO:0098855 | HCN channel complex(GO:0098855) |
| 3.4 | 16.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 3.1 | 9.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 2.8 | 11.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 2.6 | 7.8 | GO:0000802 | transverse filament(GO:0000802) |
| 2.5 | 15.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 2.4 | 7.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 2.3 | 13.8 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 2.3 | 13.6 | GO:0008091 | spectrin(GO:0008091) |
| 2.1 | 8.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 2.1 | 6.3 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 2.0 | 8.1 | GO:0043511 | inhibin complex(GO:0043511) |
| 2.0 | 2.0 | GO:0019034 | viral replication complex(GO:0019034) |
| 1.9 | 5.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.9 | 5.7 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.8 | 9.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 1.8 | 5.5 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
| 1.8 | 5.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.8 | 9.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.7 | 5.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 1.7 | 5.2 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.7 | 22.4 | GO:0044327 | dendritic spine head(GO:0044327) |
| 1.7 | 15.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.7 | 5.1 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.6 | 4.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.6 | 50.3 | GO:0030673 | axolemma(GO:0030673) |
| 1.6 | 3.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.5 | 13.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.5 | 21.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.5 | 9.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.5 | 7.4 | GO:0034704 | calcium channel complex(GO:0034704) |
| 1.4 | 4.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 1.4 | 7.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.4 | 18.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 1.4 | 4.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 1.3 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 1.3 | 4.0 | GO:0043194 | axon initial segment(GO:0043194) |
| 1.3 | 22.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 1.3 | 1.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 1.3 | 16.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 1.3 | 5.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.2 | 7.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.2 | 3.7 | GO:0071920 | cleavage body(GO:0071920) |
| 1.2 | 3.5 | GO:0045178 | basal part of cell(GO:0045178) |
| 1.2 | 5.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.1 | 1.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 1.1 | 1.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 1.1 | 3.3 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 1.1 | 19.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 1.1 | 2.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 1.1 | 8.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.1 | 4.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 1.1 | 6.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 1.0 | 12.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.0 | 7.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 1.0 | 8.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.0 | 3.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.0 | 3.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 1.0 | 5.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 1.0 | 10.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 1.0 | 2.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 1.0 | 7.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.0 | 14.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.9 | 3.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.9 | 7.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.9 | 3.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.9 | 8.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.9 | 4.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.9 | 3.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.9 | 3.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 0.9 | 2.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.9 | 16.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.9 | 18.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.9 | 3.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.9 | 13.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.8 | 3.4 | GO:0016589 | NURF complex(GO:0016589) |
| 0.8 | 11.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.8 | 1.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.8 | 5.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.8 | 4.1 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.8 | 2.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.8 | 5.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.8 | 14.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.8 | 12.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.8 | 6.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.8 | 3.2 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 0.8 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.8 | 5.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.7 | 1.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.7 | 8.9 | GO:0043203 | axon hillock(GO:0043203) |
| 0.7 | 20.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.7 | 5.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.7 | 2.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.7 | 8.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.7 | 3.7 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.7 | 5.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.7 | 19.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.7 | 2.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.7 | 1.4 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.7 | 24.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.7 | 3.5 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.7 | 1.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 0.7 | 21.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.7 | 5.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.7 | 4.0 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.7 | 2.7 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.7 | 5.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.7 | 63.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.7 | 18.6 | GO:0044298 | cell body membrane(GO:0044298) |
| 0.7 | 9.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.6 | 5.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.6 | 1.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.6 | 3.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.6 | 4.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.6 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.6 | 2.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.6 | 4.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.6 | 1.8 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.6 | 1.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.6 | 12.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.6 | 1.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.6 | 3.0 | GO:1990745 | EARP complex(GO:1990745) |
| 0.6 | 1.2 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.6 | 7.0 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.6 | 2.3 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.6 | 2.9 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.6 | 4.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.6 | 1.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.6 | 5.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.6 | 4.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.6 | 1.7 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.6 | 2.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.6 | 2.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.6 | 2.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.5 | 3.3 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.5 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.5 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.5 | 2.1 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.5 | 5.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.5 | 2.1 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
| 0.5 | 2.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.5 | 5.2 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.5 | 20.7 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.5 | 18.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.5 | 6.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.5 | 2.0 | GO:0032982 | myosin filament(GO:0032982) |
| 0.5 | 11.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.5 | 2.5 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.5 | 4.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.5 | 2.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.5 | 44.3 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.5 | 1.9 | GO:0043293 | apoptosome(GO:0043293) |
| 0.5 | 0.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.5 | 7.4 | GO:0031430 | M band(GO:0031430) |
| 0.5 | 4.1 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.5 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.5 | 0.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
| 0.5 | 2.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.4 | 5.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.4 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.4 | 4.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.4 | 5.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.4 | 1.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.4 | 4.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.4 | 2.6 | GO:0042581 | specific granule(GO:0042581) |
| 0.4 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.4 | 2.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.4 | 13.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.4 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 84.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.4 | 4.7 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.4 | 2.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.4 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 3.8 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 13.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.4 | 0.4 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 0.4 | 3.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.4 | 0.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.4 | 3.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.4 | 12.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.4 | 5.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.4 | 10.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.4 | 2.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.4 | 0.7 | GO:0097637 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.4 | 7.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.4 | 11.9 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.3 | 2.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 2.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.3 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
| 0.3 | 1.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.3 | 2.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 2.3 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 8.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.3 | 2.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 2.0 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.3 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.3 | 2.0 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 11.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.3 | 55.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.3 | 13.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.3 | 4.3 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
| 0.3 | 1.8 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 27.2 | GO:0005770 | late endosome(GO:0005770) |
| 0.3 | 7.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.3 | 1.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.3 | 13.4 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.3 | 3.9 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.3 | 5.1 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.3 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.3 | 7.4 | GO:0005776 | autophagosome(GO:0005776) |
| 0.3 | 1.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.3 | 32.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.3 | 0.9 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.3 | 1.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 2.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 3.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 0.8 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.3 | 4.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.3 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 7.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.3 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 60.7 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.3 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 1.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.3 | 2.3 | GO:0031045 | dense core granule(GO:0031045) |
| 0.3 | 3.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.3 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.3 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 0.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.2 | 14.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 31.8 | GO:0014069 | postsynaptic density(GO:0014069) |
| 0.2 | 5.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.2 | 19.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.2 | 23.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.2 | 1.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.2 | 2.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.2 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 34.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.2 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 5.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 23.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 0.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 0.4 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.2 | 2.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 0.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 1.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 0.2 | 1.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.2 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 5.1 | GO:0005903 | brush border(GO:0005903) |
| 0.2 | 0.8 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.2 | 1.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.2 | 0.6 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 5.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 5.8 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.2 | 4.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.2 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 3.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 1.7 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 9.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 12.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 1.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 3.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 6.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 1.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 361.1 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 6.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 2.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 0.2 | GO:1902636 | kinocilium(GO:0060091) kinociliary basal body(GO:1902636) |
| 0.1 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 1.0 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 3.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 2.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.1 | 0.2 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 11.9 | GO:0005768 | endosome(GO:0005768) |
| 0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 2.6 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 8.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 4.1 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.1 | 0.7 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.3 | GO:0005773 | vacuole(GO:0005773) |
| 0.0 | 0.1 | GO:0030135 | coated vesicle(GO:0030135) |
| 0.0 | 1.0 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.0 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.0 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.0 | 0.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.0 | 1.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.1 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.0 | 1.0 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 20.5 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 6.6 | 19.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 4.2 | 16.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 4.2 | 12.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 3.8 | 11.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 3.4 | 13.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 3.2 | 19.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 2.9 | 11.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 2.8 | 16.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 2.7 | 13.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 2.7 | 13.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 2.6 | 13.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 2.5 | 12.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 2.4 | 9.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 2.3 | 7.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 2.3 | 7.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 2.3 | 16.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 2.3 | 7.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 2.1 | 6.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 2.1 | 6.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 2.1 | 12.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 2.1 | 14.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 2.0 | 8.1 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 2.0 | 8.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 2.0 | 8.0 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 2.0 | 19.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.9 | 7.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 1.9 | 7.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.9 | 11.3 | GO:0097001 | ceramide binding(GO:0097001) |
| 1.8 | 5.5 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 1.8 | 9.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 1.8 | 5.4 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 1.8 | 10.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 1.7 | 5.2 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.7 | 15.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 1.7 | 5.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 1.6 | 9.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 1.6 | 4.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.6 | 6.4 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 1.6 | 4.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 1.6 | 6.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 1.6 | 6.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 1.6 | 4.7 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 1.5 | 6.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 1.5 | 9.3 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
| 1.5 | 4.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 1.5 | 12.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.5 | 6.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.5 | 6.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 1.5 | 6.0 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 1.5 | 16.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.4 | 5.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 1.4 | 7.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 1.4 | 5.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.4 | 5.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.4 | 2.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 1.4 | 4.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
| 1.4 | 4.1 | GO:0009374 | biotin binding(GO:0009374) |
| 1.4 | 8.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.3 | 5.3 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 1.3 | 11.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 1.3 | 15.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 1.3 | 3.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.3 | 3.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.3 | 7.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 1.3 | 23.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.3 | 10.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 1.3 | 9.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.3 | 5.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.3 | 13.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 1.2 | 6.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.2 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.2 | 4.9 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 1.2 | 3.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.2 | 1.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 1.2 | 3.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.2 | 3.6 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 1.2 | 1.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.2 | 2.4 | GO:0036004 | GAF domain binding(GO:0036004) |
| 1.2 | 4.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 1.2 | 5.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.2 | 10.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.2 | 29.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.1 | 16.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 1.1 | 4.6 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 1.1 | 6.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.1 | 3.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 1.1 | 3.4 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 1.1 | 15.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 1.1 | 4.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 1.1 | 6.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.1 | 4.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 1.1 | 1.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 1.1 | 1.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.1 | 3.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 1.1 | 4.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 1.1 | 4.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 1.0 | 6.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 1.0 | 2.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 1.0 | 3.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 1.0 | 7.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 1.0 | 3.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 1.0 | 3.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.0 | 3.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 1.0 | 3.0 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 1.0 | 4.0 | GO:0035473 | lipase binding(GO:0035473) |
| 1.0 | 2.9 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 1.0 | 5.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 1.0 | 2.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 1.0 | 21.5 | GO:0043274 | phospholipase binding(GO:0043274) |
| 1.0 | 1.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 1.0 | 2.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 1.0 | 3.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 1.0 | 9.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 1.0 | 6.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 1.0 | 6.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.9 | 5.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.9 | 7.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.9 | 6.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.9 | 1.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.9 | 3.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.9 | 12.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.9 | 3.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.9 | 3.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.9 | 9.3 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.9 | 16.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.9 | 3.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.9 | 4.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.9 | 11.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.9 | 3.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.9 | 3.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.9 | 2.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.9 | 2.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.9 | 6.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.9 | 3.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.9 | 2.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.9 | 6.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.9 | 3.4 | GO:0008061 | chitin binding(GO:0008061) |
| 0.8 | 3.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.8 | 4.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.8 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.8 | 10.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.8 | 11.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.8 | 7.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.8 | 18.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.8 | 2.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.8 | 3.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.8 | 14.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.8 | 3.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.8 | 3.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.8 | 2.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.8 | 3.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.8 | 7.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.8 | 2.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.8 | 2.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.8 | 3.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.8 | 6.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.8 | 3.9 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.8 | 6.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.8 | 1.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.8 | 3.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.8 | 3.0 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
| 0.7 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.7 | 3.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.7 | 5.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.7 | 1.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.7 | 13.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.7 | 8.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.7 | 3.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.7 | 2.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 0.7 | 21.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.7 | 12.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.7 | 5.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.7 | 11.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.7 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.7 | 3.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.7 | 4.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.7 | 2.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.7 | 2.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.7 | 2.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.7 | 3.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.7 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.7 | 2.0 | GO:0005118 | sevenless binding(GO:0005118) |
| 0.7 | 4.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.7 | 21.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.7 | 3.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.7 | 2.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.7 | 6.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.7 | 10.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.6 | 7.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.6 | 5.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.6 | 10.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.6 | 106.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.6 | 28.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.6 | 3.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.6 | 5.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.6 | 1.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.6 | 2.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.6 | 4.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.6 | 4.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.6 | 3.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.6 | 3.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.6 | 4.3 | GO:0070697 | activin receptor binding(GO:0070697) |
| 0.6 | 3.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.6 | 7.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.6 | 14.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.6 | 6.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.6 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.6 | 3.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.6 | 1.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 9.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.6 | 4.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.6 | 3.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.6 | 30.8 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.6 | 1.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.6 | 15.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.6 | 13.9 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
| 0.6 | 2.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.6 | 12.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.6 | 4.6 | GO:0036122 | BMP binding(GO:0036122) |
| 0.6 | 2.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.6 | 11.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.6 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.6 | 2.3 | GO:0004096 | catalase activity(GO:0004096) |
| 0.6 | 1.7 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.6 | 1.7 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.6 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.6 | 0.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.5 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.5 | 5.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.5 | 1.6 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
| 0.5 | 26.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.5 | 1.6 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.5 | 23.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.5 | 1.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.5 | 1.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.5 | 4.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.5 | 1.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.5 | 1.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.5 | 3.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.5 | 11.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.5 | 12.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.5 | 2.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.5 | 10.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.5 | 1.5 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.5 | 1.5 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
| 0.5 | 1.5 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.5 | 4.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.5 | 3.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.5 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.5 | 3.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.5 | 2.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.5 | 2.5 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 2.5 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.5 | 1.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 0.5 | 2.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.5 | 16.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.5 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.5 | 1.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.5 | 1.5 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.5 | 17.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.5 | 3.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.5 | 3.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.5 | 1.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.5 | 1.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.5 | 2.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.5 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.5 | 1.4 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.5 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.5 | 2.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.5 | 3.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.5 | 1.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.5 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.5 | 1.4 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
| 0.5 | 2.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.5 | 1.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.5 | 4.1 | GO:0031005 | filamin binding(GO:0031005) |
| 0.5 | 3.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.5 | 0.9 | GO:0051378 | serotonin binding(GO:0051378) |
| 0.5 | 5.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.4 | 4.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 0.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.4 | 6.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.4 | 3.1 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.4 | 8.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.4 | 1.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.4 | 2.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.4 | 3.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.4 | 0.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
| 0.4 | 1.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.4 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.4 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.4 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.4 | 1.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.4 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.4 | 0.4 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
| 0.4 | 2.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.4 | 3.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.4 | 3.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.4 | 4.9 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.4 | 6.4 | GO:0071949 | FAD binding(GO:0071949) |
| 0.4 | 8.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.4 | 3.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.4 | 0.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.4 | 2.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.4 | 0.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.4 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.4 | 11.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.4 | 2.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.4 | 7.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.4 | 5.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.4 | 1.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.4 | 3.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.4 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.4 | 2.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.4 | 1.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.4 | 6.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.4 | 1.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 2.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.4 | 3.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.4 | 5.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.4 | 4.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.4 | 1.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.4 | 1.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.4 | 1.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.4 | 1.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.4 | 4.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.4 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.4 | 2.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.4 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 9.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.4 | 15.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.4 | 1.4 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.4 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
| 0.4 | 1.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.4 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 16.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.4 | 30.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.4 | 1.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.3 | 6.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.3 | 6.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.3 | 2.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 1.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 9.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.3 | 2.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.3 | 2.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.3 | 1.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.3 | 1.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.3 | 1.3 | GO:0015091 | iron ion transmembrane transporter activity(GO:0005381) ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.3 | 1.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.3 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 4.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 2.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.3 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.3 | 1.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.3 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.3 | 3.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.3 | 1.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 0.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.3 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.3 | 25.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 2.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 0.9 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 0.3 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.3 | 10.5 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
| 0.3 | 1.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.3 | 2.8 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.3 | 6.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.3 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.3 | 0.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.3 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.3 | 3.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.3 | 0.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.3 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
| 0.3 | 2.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 1.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 1.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.3 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 4.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.3 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.3 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.3 | 2.0 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.3 | 1.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.3 | 5.9 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.3 | 1.9 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.3 | 51.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.3 | 0.8 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 3.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.3 | 1.1 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.3 | 1.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.3 | 10.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 5.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.3 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.3 | 25.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.3 | 0.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.3 | 3.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.3 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.3 | 1.3 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.3 | 5.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 2.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 0.2 | 8.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.2 | 9.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 5.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.2 | 2.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 7.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 2.9 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
| 0.2 | 0.7 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 2.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.2 | 3.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.2 | 1.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.2 | 1.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.2 | 0.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.2 | 3.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 1.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.2 | 2.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.2 | 0.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.2 | 2.2 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.2 | 2.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 0.7 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.2 | 2.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.2 | 0.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.2 | 0.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.2 | 3.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 0.2 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 7.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 3.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.8 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.2 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 0.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.2 | 0.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 0.6 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.2 | 0.6 | GO:0001007 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.2 | 1.6 | GO:0048038 | quinone binding(GO:0048038) |
| 0.2 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.2 | 1.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.2 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.2 | 0.4 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.2 | 0.7 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
| 0.2 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 0.7 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 1.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.2 | 0.4 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
| 0.2 | 3.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.2 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.3 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
| 0.2 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.2 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.2 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.2 | 2.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.2 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.2 | 3.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.2 | 1.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.2 | 1.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 1.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 0.5 | GO:0098809 | nitrite reductase activity(GO:0098809) |
| 0.2 | 2.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.2 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 0.5 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
| 0.2 | 0.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 6.6 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 2.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 2.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 0.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.1 | 0.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.1 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 0.7 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
| 0.1 | 0.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 1.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 9.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 1.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 0.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.1 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 3.5 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.1 | 1.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 2.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 0.5 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.1 | 1.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 3.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 2.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 0.4 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 3.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 1.8 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 3.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 3.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 1.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 2.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 46.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 5.5 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 5.4 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 1.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 5.3 | GO:0060090 | binding, bridging(GO:0060090) |
| 0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 0.4 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.1 | 0.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 12.5 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 3.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 1.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 3.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 10.7 | GO:0003779 | actin binding(GO:0003779) |
| 0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 1.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 6.3 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 2.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.1 | 0.2 | GO:0070330 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
| 0.1 | 1.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.0 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.0 | 1.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.0 | 4.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.0 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.0 | 0.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.0 | 0.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
| 0.0 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 1.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
| 0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.0 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 34.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 1.4 | 9.9 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 1.2 | 70.0 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 1.1 | 27.9 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 1.0 | 4.1 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 1.0 | 1.0 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 0.9 | 13.9 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.8 | 8.5 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 0.8 | 40.7 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.8 | 13.1 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.8 | 24.1 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.7 | 5.7 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.7 | 6.2 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.7 | 15.0 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.7 | 4.1 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.7 | 30.4 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.7 | 6.0 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.7 | 7.9 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.6 | 35.7 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.6 | 14.4 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.6 | 0.6 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
| 0.6 | 11.2 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.5 | 5.4 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.5 | 13.8 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.5 | 3.6 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.5 | 8.5 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.5 | 2.0 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.5 | 18.1 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.5 | 4.8 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.5 | 12.3 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.5 | 6.0 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.5 | 1.8 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.4 | 0.4 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.4 | 7.4 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 2.4 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.4 | 5.1 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.4 | 7.5 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.4 | 2.2 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 10.2 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.4 | 22.9 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.3 | 10.3 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.3 | 6.6 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.3 | 5.1 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.3 | 7.4 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 3.4 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.3 | 3.9 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.3 | 6.6 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 2.9 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.3 | 2.0 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 36.0 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.3 | 3.2 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 6.4 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 12.0 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.3 | 1.0 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 9.3 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.3 | 2.8 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 12.1 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.2 | 0.7 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 7.6 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 0.5 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 5.4 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 2.7 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.2 | 2.9 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.2 | 1.7 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 27.7 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 3.8 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.2 | 1.6 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.2 | 1.7 | PID_EPO_PATHWAY | EPO signaling pathway |
| 0.2 | 3.4 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 0.4 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 0.2 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 0.7 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.2 | 0.6 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 7.4 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.2 | 8.6 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 1.3 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.2 | 0.6 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 0.5 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 6.1 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 0.6 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 1.7 | PID_TCR_PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 1.9 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
| 0.1 | 0.9 | NABA_CORE_MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.1 | 2.4 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 3.4 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 0.1 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 0.2 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.5 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 14.4 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.2 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 1.9 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.6 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 2.1 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 0.7 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.1 | 1.6 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.1 | 0.1 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 0.3 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.0 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 2.1 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.1 | 0.2 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.0 | 0.7 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.0 | 0.7 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.3 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 1.1 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.0 | 2.1 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID_ARF6_PATHWAY | Arf6 signaling events |
| 0.0 | 1.3 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.0 | 0.1 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 21.6 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 2.0 | 8.1 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 1.6 | 4.8 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 1.5 | 1.5 | REACTOME_NEURONAL_SYSTEM | Genes involved in Neuronal System |
| 1.5 | 1.5 | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 1.4 | 17.3 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 1.3 | 6.6 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.3 | 3.9 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.2 | 19.9 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 1.2 | 16.0 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 1.2 | 3.6 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 1.2 | 15.2 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 1.1 | 17.1 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 1.1 | 42.5 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 1.1 | 4.4 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 1.1 | 9.5 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.0 | 12.5 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 1.0 | 2.1 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 1.0 | 10.3 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 1.0 | 13.6 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 1.0 | 2.9 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 1.0 | 18.1 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.9 | 29.7 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.9 | 2.7 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.9 | 0.9 | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.9 | 2.7 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.9 | 11.5 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.9 | 5.3 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.9 | 7.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.9 | 5.2 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.9 | 15.5 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.9 | 17.2 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.8 | 4.2 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.8 | 20.0 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.8 | 7.5 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.8 | 0.8 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 0.8 | 8.0 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.8 | 4.0 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.8 | 3.1 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
| 0.8 | 16.1 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.8 | 18.3 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.7 | 6.7 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.7 | 2.9 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.7 | 18.6 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.7 | 16.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.7 | 6.3 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.7 | 28.8 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.7 | 6.8 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.7 | 0.7 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
| 0.7 | 13.3 | REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.7 | 7.9 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.6 | 11.5 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.6 | 3.1 | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.6 | 4.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.6 | 6.8 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.6 | 8.5 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.6 | 27.3 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.6 | 7.2 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.6 | 7.1 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.6 | 13.7 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.6 | 6.4 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.6 | 1.2 | REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.6 | 10.4 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.6 | 8.6 | REACTOME_CTLA4_INHIBITORY_SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.6 | 54.5 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.5 | 5.5 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.5 | 8.7 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.5 | 14.2 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.5 | 3.1 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.5 | 11.4 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.5 | 6.5 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.5 | 2.5 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.5 | 6.5 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.5 | 3.3 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.5 | 13.2 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.5 | 7.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.5 | 3.6 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.4 | 6.1 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.4 | 9.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.4 | 8.9 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.4 | 10.8 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.4 | 17.3 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.4 | 12.5 | REACTOME_GAB1_SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.4 | 1.2 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.4 | 12.4 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.4 | 4.6 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.4 | 9.8 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.4 | 1.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 2.2 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.4 | 1.8 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.4 | 2.5 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.3 | 3.5 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 4.5 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.3 | 23.3 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 1.0 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.3 | 0.3 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.3 | 8.6 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.3 | 2.2 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.3 | 6.8 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.3 | 2.1 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.3 | 8.4 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.3 | 6.1 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.3 | 7.9 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.3 | 5.2 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.3 | 3.5 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 4.8 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.3 | 0.8 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.3 | 0.8 | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
| 0.3 | 3.4 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.3 | 3.5 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 11.5 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 6.0 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 10.3 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 0.9 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.2 | 20.2 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 8.8 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.2 | 1.5 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 3.0 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.2 | 2.3 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.2 | 1.5 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 5.0 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 9.0 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 1.1 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 1.1 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 0.2 | REACTOME_BOTULINUM_NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.2 | 1.4 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 0.5 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 3.3 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 6.3 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.1 | REACTOME_SIGNALING_BY_NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.1 | 6.3 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.1 | 1.6 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 1.4 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 1.7 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.6 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.1 | 1.8 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 2.3 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 2.7 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 0.5 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 0.8 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.3 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 1.2 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 0.5 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 4.9 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.9 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 0.6 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.6 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 0.2 | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 1.2 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 1.3 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 2.3 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 3.5 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.7 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 2.2 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 0.9 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.7 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 1.8 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 1.6 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 2.8 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.1 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 0.6 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.2 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.1 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.1 | 1.3 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 0.9 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.3 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
| 0.0 | 0.3 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.0 | 2.3 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.8 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.0 | 0.3 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 1.3 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 1.0 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.0 | 0.1 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 0.0 | 0.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.2 | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.0 | 0.4 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.1 | REACTOME_ION_CHANNEL_TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.5 | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.0 | 0.9 | REACTOME_UNFOLDED_PROTEIN_RESPONSE | Genes involved in Unfolded Protein Response |
